David S. Battleman - Net Worth and Insider Trading

David S. Battleman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David S. Battleman owns 3 companies in total, including PAVmed Inc (PAVM) , Scopus BioPharma Inc (SCPS) , and Lipella Pharmaceuticals Inc (LIPO) .

Click here to see the complete history of David S. Battleman’s form 4 insider trades.

Insider Ownership Summary of David S. Battleman

Ticker Comapny Transaction Date Type of Owner
PAVM PAVmed Inc 2017-08-03 director
SCPS Scopus BioPharma Inc 2020-12-16 director
LIPO Lipella Pharmaceuticals Inc 2022-12-19 director

David S. Battleman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David S. Battleman Ownership Network

Ownership Network List of David S. Battleman

No Data

Ownership Network Relation of David S. Battleman

Insider Network Chart

David S. Battleman Owned Company Details

What does PAVmed Inc do?

Who are the key executives at PAVmed Inc?

David S. Battleman is the director of PAVmed Inc. Other key executives at PAVmed Inc include General Counsel Michael Adam Gordon , Chief Operating Officer Shaun O'neil , and director & 10 percent owner & Chairman and CEO Lishan Aklog .

PAVmed Inc (PAVM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PAVmed Inc (PAVM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PAVmed Inc (PAVM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PAVmed Inc (PAVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

PAVmed Inc Insider Transactions

No Available Data

David S. Battleman Mailing Address

Above is the net worth, insider trading, and ownership report for David S. Battleman. You might contact David S. Battleman via mailing address: C/o Truenorth Lifesciences, 348 West 57th Street, #226, New York Ny 10019.